

[ Tue, Jan 23rd 2018
] - WOPRAI
[ Tue, Jan 23rd 2018
] - WOPRAI
[ Tue, Jan 23rd 2018
] - WOPRAI
[ Tue, Jan 23rd 2018
] - WOPRAI
[ Tue, Jan 23rd 2018
] - WOPRAI
[ Tue, Jan 23rd 2018
] - WOPRAI
[ Tue, Jan 23rd 2018
] - WOPRAI
[ Tue, Jan 23rd 2018
] - WOPRAI
[ Tue, Jan 23rd 2018
] - WOPRAI
[ Tue, Jan 23rd 2018
] - WOPRAI
[ Tue, Jan 23rd 2018
] - WOPRAI

[ Mon, Jan 22nd 2018
] - WOPRAI
[ Mon, Jan 22nd 2018
] - WOPRAI
[ Mon, Jan 22nd 2018
] - WOPRAI

[ Fri, Jan 19th 2018
] - WOPRAI
Corey Davis Initiated (VNDA) at Strong Buy and Held Target at $20 on, Jan 19th, 2018
Corey Davis of Seaport Global, Initiated "Vanda Pharmaceuticals Inc." (VNDA) at Strong Buy and Held Target at $20 on, Jan 19th, 2018.
Corey has made no other calls on VNDA in the last 4 months.
There is 1 other peer that has a rating on VNDA. Out of the 1 peers that are also analyzing VNDA, 0 agree with Corey's Rating of Hold.
This is the rating of the analyst that currently disagrees with Corey
- Derek Archila of "Oppenheimer" Maintained at Buy with Increased Target to $26 on, Monday, October 30th, 2017
Contributing Sources
Similar Stocks and Investing Articles
[ Wed, Jan 10th 2018
] - WOPRAI
[ Thu, Jan 04th 2018
] - WOPRAI
[ Fri, May 26th 2017
] - WOPRAI
[ Thu, Jan 19th 2017
] - WOPRAI
[ Tue, Jan 10th 2017
] - WOPRAI
[ Fri, Mar 04th 2016
] - WOPRAI
[ Fri, May 09th 2014
] - WOPRAI
[ Fri, Jan 24th 2014
] - WOPRAI
[ Fri, Jan 24th 2014
] - WOPRAI
[ Thu, Apr 19th 2012
] - WOPRAI